Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Core One Labs Inc. C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. The Company, through its wholly owned subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics.


CSE:COOL - Post by User

Bullboard Posts
Comment by redwings6on Jul 01, 2019 7:36pm
112 Views
Post# 29878774

RE:RE:RE:RE:Fair Valuation

RE:RE:RE:RE:Fair Valuation Vancouver, British Columbia--(Newsfile Corp. - January 29, 2019) -  TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8) ("TransCanna" or the "Company") is pleased to announce that it has signed a non-binding Letter of Intent to acquire Goodfellas Group, LLC, ("Goodfellas") a full service advertising and marketing agency for the cannabis and hemp industries, from which the Company is already acquiring 23 branding agreements. The acquisition price will be derived from two times the previous 12 months revenues, at the time of execution of definitive agreements, as set forth in the audited financial statements of Goodfellas. 60% of acquisition price will be paid at closing, of which ½ will be payable in cash and ½ will be payable through the issuance of the Company's common shares, and the remaining 40% of the acquisition price will be paid 12 months following the closing. The Company also anticipates retaining key members of the Goodfellas staff.
Bullboard Posts